Cite
HARVARD Citation
Vernieri, C. et al. (2020). LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. ESMO open. 5 (3), p. . [Online].